Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Helix BioPharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 11
Helix BioPharma to Enter into Agreement with ProMab Biotech 12
Amorfix Life Sciences Enters Into Co-Development Agreement With Helix BioPharma 13
Licensing Agreements 14
Helix BioPharma Enters into Licensing Agreement with National Research Council of Canada 14
Xisle Pharma Ventures Trust Enters into Licensing Agreement with Helix BioPharma 15
Helix Polska Enters into Licensing Agreement with Helix BioPharma 16
Equity Offering 17
Helix BioPharma Raises USD3 Million in Private Placement of Units 17
Helix BioPharma Raises USD1 Million in Private Placement of Units 18
Helix BioPharma Raises USD2.3 Million in Private Placement of Units 19
Helix BioPharma Raises USD0.6 Million in Private Placement of Units 20
Helix BioPharma Raises USD0.2 Million in Second Tranche of Private Placement of Units 21
Helix BioPharma Raises USD1 Million in Private Placement of Units 22
Helix BioPharma Raises USD1.4 Million in Private Placement of Units 23
Helix BioPharma Raises USD3.58 Million in Private Placement of Units 24
Helix BioPharma Raise Funds in Private Placement of Shares and Warrants 25
Helix BioPharma Raises Funds in Private Placement of Shares and Warrants 26
Helix BioPharma Raises Funds through Private Placement of Shares and Warrants 27
Helix BioPharma Completes Private Placement Of Common Stock And Warrants 28
Helix BioPharma Completes Private Placement Of Units For US$4.03 Million 29
Asset Transactions 30
Helix BioPharma Completes Sale Of Rivex Pharma To Pharmascience For US$8.6 Million 30
Helix BioPharma Corp – Key Competitors 32
Helix BioPharma Corp – Key Employees 33
Helix BioPharma Corp – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Oct 27, 2017: Helix BioPharma Announces Fiscal 2017 Year-End Results and Provides Research and Development Program Update 35
Jun 13, 2017: Helix BioPharma Announces Fiscal Third Quarter 2017 Results 37
Mar 17, 2017: Helix BioPharma Announces Fiscal Second Quarter 2017 Results 39
Dec 13, 2016: Helix BioPharma Announces Fiscal First Quarter 2017 Results 40
Oct 31, 2016: Helix BioPharma Announces Fiscal 2016 Results 41
Jun 14, 2016: Helix BioPharma Announces Third Quarter Fiscal 2016 Results 42
Mar 16, 2016: Helix Biopharma Announces Second Quarter Fiscal 2016 Results 43
Corporate Communications 44
Dec 01, 2017: Helix BioPharma Announces Management Change 44
Jul 17, 2017: Helix BioPharma Director Resigns 45
Mar 07, 2017: Helix BioPharma Announces Strategic Management Changes 46
Sep 07, 2016: Helix BioPharma Announces New Director Appointment 47
Apr 20, 2016: Helix BioPharma Announces Important Additions to Its Leadership Team 48
Mar 29, 2016: Helix BioPharma Announces CEO Change 49
Feb 04, 2016: Changes in the Leadership of Helix Polska 50
Jan 29, 2016: Helix BioPharma Announces Appointment of New Directors to the Board of Directors 51
Jan 12, 2016: Helix BioPharma Announces Appointment of Permanent New CEO and Changes at Board Level 52
Product News 53
10/19/2016: Helix BioPharma Announces CAR-T Poster Presentation at the AACR Conference on Tumor Immunology and Immunotherapy 53
07/21/2016: Helix BioPharma, Subsidiary, Helix Polska, Finalizes Grant Funding With the Polish National Center for Research and Development 54
05/09/2016: Helix BioPharma Subsidiary, Helix Polska Qualifies for CAD4.1 Million Grant From the Polish National Center for Research and Development 55
Other Significant Developments 56
Jun 02, 2016: Helix BioPharma Appoints Evolution Life Science Partners as Advisors 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Helix BioPharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Helix BioPharma Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Helix BioPharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 11
Helix BioPharma to Enter into Agreement with ProMab Biotech 12
Amorfix Life Sciences Enters Into Co-Development Agreement With Helix BioPharma 13
Helix BioPharma Enters into Licensing Agreement with National Research Council of Canada 14
Xisle Pharma Ventures Trust Enters into Licensing Agreement with Helix BioPharma 15
Helix Polska Enters into Licensing Agreement with Helix BioPharma 16
Helix BioPharma Raises USD3 Million in Private Placement of Units 17
Helix BioPharma Raises USD1 Million in Private Placement of Units 18
Helix BioPharma Raises USD2.3 Million in Private Placement of Units 19
Helix BioPharma Raises USD0.6 Million in Private Placement of Units 20
Helix BioPharma Raises USD0.2 Million in Second Tranche of Private Placement of Units 21
Helix BioPharma Raises USD1 Million in Private Placement of Units 22
Helix BioPharma Raises USD1.4 Million in Private Placement of Units 23
Helix BioPharma Raises USD3.58 Million in Private Placement of Units 24
Helix BioPharma Raise Funds in Private Placement of Shares and Warrants 25
Helix BioPharma Raises Funds in Private Placement of Shares and Warrants 26
Helix BioPharma Raises Funds through Private Placement of Shares and Warrants 27
Helix BioPharma Completes Private Placement Of Common Stock And Warrants 28
Helix BioPharma Completes Private Placement Of Units For US$4.03 Million 29
Helix BioPharma Completes Sale Of Rivex Pharma To Pharmascience For US$8.6 Million 30
Helix BioPharma Corp, Key Competitors 32
Helix BioPharma Corp, Key Employees 33
Helix BioPharma Corp, Subsidiaries 34